More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC, the flagship journal of the American College of Cardiology, ...

New research suggests that a procedure now regarded as Plan B when patients have episodes of rapid heartbeat after a ...

At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular ...

The combination of sacubitril and valsartan reduces the cardiotoxicity related to anthracycline chemotherapy drugs, according ...

Inflammation is generally the indication of a health problem. But new research suggests we think differently about inflammation, especially in relation to heart disease and the prevention of atheroscl ...

Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new research shows.

A new nasal spray form of the medication bumetanide may reduce the tissue swelling caused by heart failure as effectively as ...

Among participants in the landmark ORAL Surveillance study assigned to the JAK inhibitor tofacitinib (Xeljanz) and also using ...

Administrating life-saving drugs for cardiac arrest directly into the bone does not improve survival rates compared to the ...